Postpartum Adherence Clubs to Enhance Support: the PACER Study
PACER
2 other identifiers
interventional
258
1 country
1
Brief Summary
The Western Cape province of South Africa (SA) is changing the way it treats pregnant women with HIV. Now, all HIV-infected pregnant women, regardless of how sick or healthy they are, will receive antiretroviral treatment (ART) for life ("Option B+"). However, there are few well-developed models of service delivery to support this change to "Option B+" in the Western Cape and many parts of the continent. The parent study -- Strategies to Optimize ART Services for Maternal \& Child Health (MCH-ART)-- is testing two clinic-based models of service delivery for Option B+ . To complement MCH-ART, this study, PACER, will test whether community-based Adherence Clubs are an effective model for keeping breastfeeding women in HIV care after pregnancy. These clubs have been used to free up space at ART clinics by moving stable HIV+ patients to community-based services, but they have not been studied as an effective strategy among breastfeeding women after delivery. PACER seeks to address this gap.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv
Started Feb 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 1, 2015
CompletedFirst Posted
Study publicly available on registry
April 16, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2016
CompletedFebruary 13, 2018
February 1, 2018
1.7 years
April 1, 2015
February 12, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maternal retention
Proportion of mothers retained in HIV care and adhering to ART at 12 months postpartum
12 months
Secondary Outcomes (5)
Maternal Loss to Follow-up
12 months
Maternal Viral Suppression
12 months
Infant HIV diagnosis
12 months
Infant vaccination
12 months
Mother-to-child transmission
12 months
Study Arms (2)
Standard of Care (SOC)
ACTIVE COMPARATORWomen who choose the SOC will receive postpartum antiretroviral therapy (ART) services at their nearest primary care clinic, following the Standard of Care for Mothers. Details are provided in the intervention description. Infants receive the same care in each arm, according to the Standard of Care for Infants.
Intervention (AC)
EXPERIMENTALWomen who choose the Community-based Adherence Clubs (AC) will receive postpartum antiretroviral therapy (ART) services at an AC, rather than at their nearest primary care clinic as in the SOC arm. Details are provided in the intervention section. Infants receive the same care in each arm, according to the Standard of Care for Infants.
Interventions
Women in the AC arm are prescribed 2 months of their current ART medication (compared to 1 month in the SOC) and will be advised to go to the AC office immediately, where they will be scheduled for their first session. Women will attend AC meetings every two months. At these meetings, women will receive a 2 month supply of medication, health education and peer-support. A trained Community Health Worker (CHW) will also collect blood samples, weight, and current signs/symptoms from women. Each participant has 5 working days after their AC session to come and collect her medication. Those who have defaulted will be followed up by the CHW via phone calls and, possibly, home visits. If reached, women will be told to return immediately to the main ART facility for receipt of ART care.
Women will be referred immediately from the maternity ART clinic to their nearest adult ART clinic at their first postpartum clinic visit. At referral, they receive an initial 1-month supply of their current ART medication. At the first appointment after transfer into the general ART service, patients undergo clinical history and examination by a doctor or clinical nurse practitioner. Laboratory investigations are ordered according to standard protocols or based on clinician discretion. For the 1st 4 months in the new service, stable patients are dispensed 1 month of ART; subsequent visits are 2-monthly for medication refill, with clinician review 6-monthly; patients with particular clinical or psychosocial concerns may be reviewed more regularly, or referred to higher levels of care.
All infants will receive care at their nearest primary care clinic. Following national protocols, all HIV-infected mothers are issued a 6-week supply of nevirapine syrup after delivery and counselled on daily nevirapine prophylaxis. Infant follow-up takes place within 1 week postpartum with the mother (at the MOU) and then at 6 weeks postpartum (at the nearest primary care clinic) when HIV PCR testing of the infant is carried out. Following national protocols, infants who are breastfed beyond 6 weeks receive HIV PCR testing 2-4 weeks after the cessation of breastfeeding, again conducted at the nearest City of Cape Town primary care clinic.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Documented HIV-infection according to two finger-prick rapid tests using different test types (per routine protocol in this setting) or documentation of HIV status for those women self reporting HIV diagnosis.
- Initiated ART during the antenatal period (during most recent pregnancy)
- Within one month postpartum
- Currently breastfeeding within one month postpartum
- Willingness to return for postnatal study visits
- Able to provide informed consent for research
- Eligible to receive care at local Adherence Club, based on following local eligibility criteria:
- Virally suppressed (HIV RNA \<1000 copies/mL) per most recent viral load test (conducted during pregnancy)
- Clinically stable (no active co-morbidity including opportunistic infections)
- Current resident of a catchment area appropriate for Adherence Club referral
- Infants of women enrolled in the study.
You may not qualify if:
- Receipt of any ART services outside the Gugulethu MOU ART service in the postpartum period
- Intention to relocate out of Cape Town permanently during the following one year
- Any medical, psychiatric or social condition which in the opinion of the investigators would affect the ability to consent and/or participate in the study, including:
- Refusal to take ART/ARVs
- Denial of HIV status
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gugulethu Community Health Centre
Cape Town, Western Cape, South Africa
Related Publications (2)
Zerbe A, Brittain K, Phillips TK, Iyun VO, Allerton J, Nofemela A, Kalombo CD, Myer L, Abrams EJ. Community-based adherence clubs for postpartum women on antiretroviral therapy (ART) in Cape Town, South Africa: a pilot study. BMC Health Serv Res. 2020 Jul 8;20(1):621. doi: 10.1186/s12913-020-05470-5.
PMID: 32641032DERIVEDTrafford Z, Gomba Y, Colvin CJ, Iyun VO, Phillips TK, Brittain K, Myer L, Abrams EJ, Zerbe A. Experiences of HIV-positive postpartum women and health workers involved with community-based antiretroviral therapy adherence clubs in Cape Town, South Africa. BMC Public Health. 2018 Jul 31;18(1):935. doi: 10.1186/s12889-018-5836-4.
PMID: 30064405DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elaine J Abrams, MD
ICAP at Columbia University
- PRINCIPAL INVESTIGATOR
Landon Myer, MD
University of Cape Town
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Research Director, ICAP
Study Record Dates
First Submitted
April 1, 2015
First Posted
April 16, 2015
Study Start
February 1, 2015
Primary Completion
October 31, 2016
Study Completion
October 31, 2016
Last Updated
February 13, 2018
Record last verified: 2018-02